Researchers at MIT have developed a new AI model capable of assessing a patient’s risk of pancreatic cancer, reports Erez Meltzer for Forbes. “The model could potentially expand the group of patients who can benefit from early pancreatic cancer screening from 10% to 35%,” explains Meltzer. “These kinds of predictive capabilities open new avenues for preventive care.”
MIT researchers have developed a biosensor “the size of a stick of gum that can be implanted under the skin and deliver naloxone if vital signs indicate an overdose,” reports David Ovalle and Elana Gordon for The Washington Post.
The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros '75, PhD '79 and Gary Ruvkun for the discovery of microRNA, “a tiny class of RNA molecules that play a crucial role in determining how organisms mature and function – and how they sometimes malfunction,” reports Teddy Rosenbluth and Derrick Bryson Taylor for The New York Times. Ambros and Ruvkun “had been postdoctoral fellows at the same time at Massachusetts Institute of Technology,” they explain . “As they studied C. elegans, they at first felt a smidgen of friendly competition as they each started their own labs in the Boston area, Dr. Ambros said.”
Victor Ambros '75, PhD '79 and Gary Ruvkun have won the 2024 Nobel Prize in Physiology or Medicine for the discovery of microRNAs, report Mark Johnson and Lizette Ortega for The Washington Post. “Ambros and Ruvkunhad worked together as postdoctoral researchers in the lab of Nobel laureate and MIT Professor Robert Horvitz. “What the microRNAs really end up revealing for us is a way that parts of our genome can communicate with other parts of the genome,” says Ambros. “The significance of this discovery of microRNAs is that it allowed us to be aware of a very complex and nuanced layer of regulation whereby genes in our cells talk to each other.”
Profs. Canan Dagdeviren and Hugh Herr speak with CNN discuss their work aimed at empowering patients and doctors. Inspired by her aunt’s experience with breast cancer, Dagdeviren and her students are developing new wearable devices that could help detect cancer at an earlier stage. Says Herr of his work developing prosthetics that can be controlled by the human nervous system: “There will be a point where technology is so sophisticated that we can actually rebuild limbs after amputation that will be as good and, ultimately, they will be better than intact biological limbs.” Herr adds that in the future he hopes “the conversation will not be about human limitation anymore. It will be about human ability and human expression.”
Victor Ambros ‘75, PhD ‘79 and Gary Ruvkun have won the 2024 Nobel Prize in Physiology or Medicine for “their groundbreaking work on how genes behave,” reports Patrick Smith for NBC News. Ambros and Ruvkun, who worked as postdocs in the lab of Professor H. Robert Horvitz in the late 1980s, discovered how microRNA molecules play a key role in gene regulation. "The pair sought to explore how nerve cells and muscle cells, for example, have very different characteristics despite having the same genetic information," writes Smith.
Prof. Regina Barzilay has received the WebMD Health Heros award for her work developing a new system that uses AI to detect breast cancer up to 5 years earlier, reports WHDH. “We do have a right to know our risk and then we, together with our healthcare providers, need to manage them,” says Barzilay.
CNN visits the lab of Prof. Canan Dagdeviren to learn more about her work developing wearable ultrasound devices that could help screen for early-stage breast cancer, monitor kidney health, and detect other cancers deep within the body. “Wearable technology will grow rapidly in the near future,” says Dagdeviren. “But in the far future, they will be one of the most powerful tools that we will be seeing in our daily life.”
Dr. Mark Price PhD '01 an orthopedic surgeon who augmented his military honors with Super Bowl rings in 2017 and 2019 and a World Series ring in 2018 through his sports medicine duties with the Patriots and Red Sox, has died at age 52, reports Bryan Marquard for The Boston Globe. Awarded a Bronze Star for service in Afghanistan, Price was an integral part of the Red Sox and Patriots organizations, with owner Robert Kraft commenting he “was a blessing to have on our staff for nearly a decade and we’re going to miss him dearly.”
Researchers at MIT and elsewhere have developed a new device “designed to detect the signs of an overdose and automatically deliver a dose of naloxone in as little as 10 seconds,” reports Tom Hawking for Popular Science. “The device [which has an associated smartphone app] also has a built-in alert system with auditory and tactile signals to wake the user, providing an alternative for those without smartphones or with uncharged devices,” says Prof. Giovanni Traverso.
Interesting Engineering reporter Shubhangi Dua describes a new implantable device developed by MIT researchers that can detect and automatically treat an opioid overdose. “Having an automated robotic system that can sense and reverse opiate overdose could be transformational,” says Prof. Giovanni Traverso, “particularly for high-risk populations.”
MIT scientists have developed an implantable sensor that could “detect the signs of an overdose and automatically deliver a dose of naloxone in as little as 10 seconds,” reports Tom Hawking for Popular Science. "The long-term benefits of preventing fatal overdoses and reducing healthcare costs related to overdose treatment are significant factors that support the value of this technology,” explains Prof. Giovanni Traverso.
MIT researchers have discovered how propofol, a commonly used anesthetic, works on the brain, reports Francesca Benson for IFL Science. The research studied “the differences between an awake brain and one under anesthesia by looking at the stability of the brain’s activity,” writes Bensen.
MIT scientists have discovered how propofol, a commonly used anesthetic, induces unconsciousness, reports Adam Kovac for Gizmodo. “The new research indicates that [propofol] works by interfering with a brain’s ‘dynamic stability’ – a state where neurons can respond to input, but the brain is able to keep them from getting too excited,” explains Kovac.
Prof. Bob Langer and Prof. Giovanni Traverso have co-founded Syntis Bio, a biotech company that will use technology to “coat the stomach and potentially other organ surfaces, [change] the way that drugs are absorbed or, in the case of obesity, which hormones are triggered,” reports Allison DeAngelis for STAT.